Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo

Cesana, Daniela, Ranzani, Marco, Volpin, Monica, Bartholomae, Cynthia, Duros, Caroline, Artus, Alexandre, Merella, Stefania, Benedicenti, Fabrizio +11 more·2014·Molecular Therapy
DOI 10.1038/mt.2014.3

Cited by (189)

Items 101–189 of 189

  1. Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy
    Eugenio Montini, Luigi Naldini, Claire Booth, Donald B. Kohn, Alessandro Aiuti · 2024 · Molecular Therapy
  2. Effective therapies for sickle cell disease: are we there yet?
    Merlin Crossley, Georgios E. Christakopoulos, Mitchell J. Weiss · 2022 · Trends in Genetics
  3. Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
    Alessandra Rossi, Zuleika Michelini, Pasqualina Leone, Martina Borghi, Maria Blasi, Roberta Bona, Massimo Spada, Felicia Grasso, Alessio Gugliotta, Mary E. Klotman et al. · 2014 · PLoS ONE
  4. Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector
    Singh, Swati, Khan, Iram, Khim, Socheath, Seymour, Brenda, Sommer, Karen, Wielgosz, Matthew, Norgaard, Zachary, Kiem, Hans-Peter, Adair, Jennifer, Liggitt, Denny et al. · 2017 · Molecular Therapy - Methods & Clinical Development
  5. Gene therapy's out-of-body experience
    Christopher Thomas Scott, Laura DeFrancesco · 2016 · Nature Biotechnology
  6. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies
    Myriam Lemmens, Lena Dorsheimer, Andreas Zeller, Yasmin Dietz · 2024 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  7. The Current Landscape of Secondary Malignancies after CAR T-Cell Therapies: How Could Malignancies Be Prevented?
    Stella Bouziana, Dimitrios Bouzianas · 2024 · International Journal of Molecular Sciences
  8. Insulated Foamy Viral Vectors
    D. Browning, Casey Collins, Jonah D. Hocum, David J. Leap, Dustin T. Rae, G. Trobridge · 2016 · Human Gene Therapy
  9. Viral vectors as a promising nanotherapeutic approach against neurodegenerative disorders
    Vaibhavi Srivastava, Ajit Singh, Gaurav Kumar Jain, Farhan Jalees Ahmad, Rahul Shukla, Prashant Kesharwani · 2021 · Process Biochemistry
  10. Evidence for the in vivo safety of insulated foamy viral vectors
    Diana L. Browning, Elizabeth M. Everson, David J. Leap, Jonah D. Hocum, H Wang, George Stamatoyannopoulos, G D Trobridge · 2016 · Gene Therapy
  11. The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
    Sabina Sánchez-Hernández, Alejandra Gutiérrez-Guerrero, Rocío Martín-Guerra, Marina Cortijo-Gutierréz, María Tristán‐Manzano, Sandra Rodríguez, Laura Sánchez, Jose Luis Garcia-Perez, Jesús Chato‐Astrain, Ricardo Fernández‐Valadés et al. · 2018 · Molecular Therapy — Nucleic Acids
  12. In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy
    Yingyu Chen, Jocelyn A. Schroeder, Chunyan Gao, Jing Li, Jianda Hu, Qizhen Shi · 2020 · Journal of Cellular Physiology
  13. Barcoding of Macaque Hematopoietic Stem and Progenitor Cells: A Robust Platform to Assess Vector Genotoxicity
    Idalia M. Yabe, Lauren L. Truitt, Diego A. Espinoza, Chuanfeng Wu, Samson Koelle, Sandhya Ramanathan Panch, Marcus Alexandre Finzi Corat, Thomas Winkler, Kyung–Rok Yu, So Gun Hong et al. · 2018 · Molecular Therapy — Methods & Clinical Development
  14. Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case
    Pilar Puig-Serra, Ana Hinckley-Boned, María Tristán‐Manzano, Paula Rı́o, Raúl Torres-Ruiz, Sandra Rodríguez, Francisco Martı́n · 2025 · Human Gene Therapy
  15. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
    Roberta Bona, Zuleika Michelini, Chiara Mazzei, Alessandra Gallinaro, Andrea Canitano, Martina Borghi, Maria Fenicia Vescio, Antonio Di Virgilio, Maria Franca Pirillo, Mary E. Klotman et al. · 2021 · Molecular Therapy — Methods & Clinical Development
  16. InsB9-23 Gene Transfer to Hepatocyte-Based Combined Therapy Abrogates Recurrence of Type 1 Diabetes After Islet Transplantation
    Fabio Russo, Antonio Citro, Giorgia Squeri, Francesca Sanvito, Paolo Monti, Silvia Gregori, Maria Grazia Roncarolo, Andrea Annoni · 2020 · Diabetes
  17. Canstatin represses glioma growth by inhibiting formation of VM-like structures
    Yuqiang Ma, Tao Wu, Houjie Zhou, Guilu He, Yifei Li, Bocheng Wang, Qiang Guo, Baodong Chen, Weiping Li · 2021 · Translational Neuroscience
  18. Genome Editing of the Blood: Opportunities and Challenges
    Matthew Hebden Porteus · 2015 · Current Stem Cell Reports
  19. Hepatotoxicity and Toxicology of In Vivo Lentiviral Vector Administration in Healthy and Liver-Injury Mouse Models
    Robert A. Kaiser, Clara T. Nicolas, Kari L. Allen, Jennifer A. Chilton, Zeji Du, Raymond Hickey, Joseph B. Lillegard · 2019 · Human Gene Therapy Clinical Development
  20. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation
    Simone Scholz, Raffaele Fronza, Cynthia C. Bartholomae, Daniela Cesana, Eugenio Montini, Christof V. Kalle, Irene Gil-Fariña, Manfred Schmidt · 2017 · Human Gene Therapy
  21. Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side
    Laura García-Pérez, Anita Ordas, Kirsten Canté-Barrett, Pauline Meij, Karin Pike‐Overzet, Arjan C. Lankester, Frank J. T. Staal · 2020 · Pharmaceutics
  22. Integrome signatures of lentiviral gene therapy for SCID-X1 patients
    Koon‐Kiu Yan, Jose Condori, Zhijun Ma, Jean‐Yves Métais, Bensheng Ju, Liang Ding, Yogesh Dhungana, Lance E. Palmer, Deanna M. Langfitt, Francesca Ferrara et al. · 2023 · Science Advances
  23. Quantum pBac : An effective, high‐capacity piggyBac ‐ based gene integration vector system for unlocking gene therapy potential
    Wei‐Kai Hua, Jeff C. Hsu, Yi‐Chun Chen, Peter S. Chang, Kuo‐Lan Karen Wen, Po‐Nan Wang, Wei‐Cheng Yang, Chia‐Ning Shen, Yishan Yu, Ying‐Chun Chen et al. · 2023 · The FASEB Journal
  24. Safety and Efficacy of Retroviral and Lentiviral Vectors for Gene Therapy
    Daniela Cesana, Monica Volpin, Yasmin Natalia Serina Secanechia, Eugenio Montini · 2017 · Springer eBooks
  25. The steep uphill path leading to ex vivo gene therapy for genodermatoses
    Michele Palamenghi, Michele De Luca, Laura De Rosa · 2022 · American Journal of Physiology-Cell Physiology
  26. Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
    Eline Pellaers, Anayat Bhat, Frauke Christ, Zeger Debyser · 2022 · Viruses
  27. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article
    Jan C Klapwijk, Alberto del Río Espínola, S. Libertini, P. Collin, Mick D. Fellows, Susan Jobling, Anthony M. Lynch, H. Martus, Catherine Vickers, Andreas Zeller et al. · 2024 · Human Gene Therapy
  28. Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy
    Penelope Georgia Papayanni, Nikoletta Psatha, Panayota Christofi, Li X, Pâmela Melo, Monica Volpin, Eugenio Montini, Mingdong Liu, Georgios Kaltsounis, Minas Yiangou et al. · 2021 · Human Gene Therapy
  29. Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head
    Zhenhong Zhu, Wenqi Song, Changqing Zhang, Jimin Yin · 2016 · Experimental and Therapeutic Medicine
  30. Mutagenesis and Carcinogenesis Risk Evaluation for AAV and Lentiviral Gene Therapies
    Toufan Parman, Daniella M. Pizzurro, Jacquelynn Lucas, Zhechu Peng · 2025 · International Journal of Toxicology
  31. Adaptation of lentiviral vectors for viral gene therapy and their impact on host cell biology
    Catherine W. Kaiser, Eric Christian Rouchka, Melissa L. Smith · 2026 · Journal of Translational Medicine
  32. Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models
    Evangelia Yannaki, Nikoletta Psatha, Αναστασία Παπαδοπούλου, Takis Athanasopoulos, Achilleas Gravanis, Maria G. Roubelakis, Panagiotis D. Tsirigotis, Αchilles Anagnostopoulos, Nicholas P. Anagnou, George Vassilopoulos · 2021 · Human Gene Therapy
  33. Tightly regulated ‘all-in-one’ lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy
    Nico Lachmann, Sebastian Brennig, Roman Hillje, H Schermeier, Ruhi Phaltane, Julia Dahlmann, Ina Gruh, Niels Heinz, Bernhard Schiedlmeier, C Baum et al. · 2015 · Gene Therapy
  34. Multiple Genes Surrounding Bcl-x L , a Common Retroviral Insertion Site, Can Influence Hematopoiesis Individually or in Concert
    Teng-Cheong Ha, Maike Stahlhut, Michael Rothe, Gabi Paul, Violetta Dziadek, Michael Alexander Morgan, Martijn H. Brugman, Boris Fehse, Olga S. Kustikova, Axel Schambach et al. · 2020 · Human Gene Therapy
  35. Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy
    Sungjun Kwak, Hyo‐Jeong Lee, Dongjun Yu, Tae‐Joon Jeon, Sun Min Kim, Hyunil Ryu · 2025 · Biosensors
  36. On the road to in vivo CAR-T success: Comparing promising viral and non-viral vectors.
    Sarah de la Mota, L. Suchet, M. van Wijk, D. Stibbs, Pedro Silva Couto, Qasim A. Rafiq · 2026 · Biotechnology Advances
  37. Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells
    Vasileios Lazaris, Emmanouil Simantirakis, Eleana F. Stavrou, Meletios Verras, Argyro Sgourou, Maria K. Keramida, George Vassilopoulos, Aglaia Athanassiadou · 2023 · Genes
  38. Regulatory issues for genetically modified animals
    Perry B. Hackett · 2020 · Frontiers of Agricultural Science and Engineering
  39. Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells
    Kathleen M. Broughton, Kelli Korski, Oscar Echeagaray, Robert M. Adamson, Walter P. Dembitsky, Zhibing Lu, Erik M. SCHAEFER, Mark Alan Sussman · 2019 · Gene Therapy
  40. Editing T cell repertoire by thymic epithelial cell-directed gene transfer abrogates risk of type 1 diabetes development
    Fabio Russo, Eliana Ruggiero, Rosalia Curto, Laura Passeri, Francesca Sanvito, Ileana Bortolomai, ANNA MARIA VILLA, Silvia Gregori, Andrea Annoni · 2022 · Molecular Therapy — Methods & Clinical Development
  41. Delivery of RNA-based molecules to human hematopoietic stem and progenitor cells for modulation of gene expression
    Yvonne Diener, Andreas Bosio, Ute Bissels · 2016 · Experimental Hematology
  42. Hematopoietic stem cell gene therapy for the treatment of X-linked agammaglobulinemia
    Christopher R. Luthers, Annika Mittelhauser, A. Colamartino, Wu Xiaomeng, Samuel Cirigliano, Joseph D. Long, Julie M. Sanchez, Zulema G. Romero, Donald B. Kohn · 2025 · Molecular Therapy — Methods & Clinical Development
  43. Promises and Challenges in Hematopoietic Stem Cell Gene Therapy
    Saskia Kohlscheen, Halvard B. Bonig, Ute Modlich · 2017 · Human Gene Therapy
  44. WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation
    Pilar Muñoz, María Tristán‐Manzano, Almudena Sánchez‐Gilabert, Giorgia Santilli, Anne H. M. Galy, Adrian James Thrasher, Francisco Martı́n · 2020 · Molecular Therapy — Methods & Clinical Development
  45. Characterization of an immune-evading doxycycline-inducible lentiviral vector for gene therapy in the spinal cord
    Fred de Winter, Isaac Francos-Quijorna, Emily R. Burnside, Barbara Hobo, Ruben Eggers, Stefan A. Hoyng, H.P. Mulder, Rob C. Hoeben, Elizabeth M. Muir, Elizabeth J. Bradbury et al. · 2022 · Experimental Neurology
  46. Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo
    Sebastian Wagner, Christoph Baldow, Andrea Calabria, Laura Rudilosso, Pierangela Gallina, Eugenio Montini, Daniela Cesana, Ingmar Glauche · 2022 · Nature Communications
  47. Tagmentation-based analysis reveals the clonal behavior of CAR-T cells in association with lentivector integration sites
    Jaeryuk Kim, Mi‐Young Park, Gyung Won Baek, Joo-Il Kim, Euna Kwon, Byeong‐Cheol Kang, Jong‐Il Kim, Hyoung Jin Kang · 2023 · Molecular Therapy — Oncolytics
  48. High level of fetal-globin reactivation by designed transcriptional activator-like effector
    Jun Zhan, Maria Johnson Irudayam, Yukio Nakamura, Ryo Kurita, Arthur W. Nienhuis · 2020 · Blood Advances
  49. Erosion of the pump mechanism of an inflatable penile prosthesis through the scrotum in a diabetic patient.
    Ihor S. Sawczuk, Michael E. Wechsler · 1985 · PubMed Central
  50. The long road traveled in hematopoietic stem cell gene therapy
    David A. Williams · 2022 · Molecular Therapy
  51. Clonal tracing of blood stem cells across mouse and human lifespans
    Alejo Rodriguez-Fraticelli · 2025 · Blood
  52. Gene therapy for Parkinson’s disease—Ample room for optimism
    Ivette M. Sandoval, Michael F. Salvatore, Fredric P. Manfredsson · 2025 · Current Opinion in Neurobiology
  53. Harnessing lentiviral vectors for in vivo gene therapy of liver metastases
    Giovanna Giacca, Luigi Naldini, Mario Leonardo Squadrito · 2024 · Clinical and Translational Medicine
  54. The cHS4 Chromatin Insulator Reduces the Rate of Retroviral Vector-Mediated Gene Dysregulation Associated with Aberrant Vector Transcription
    Xianyao Zhou, Qiujun Liu, Da Wang, Xuemei Zhang, David W. Emery, Chang Long Li · 2017 · Cytogenetic and Genome Research
  55. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells
    Elizabeth M. Everson, Jonah D. Hocum, Grant D. Trobridge · 2018 · The Journal of Gene Medicine
  56. A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors
    Anna Hartley, Luisa Burger, Cornelia L. Wincek, Lieke Dons, Tracy M.W.Y. Li, Annabel Grewenig, Toros Taşgın, Manuela B. Urban, Alicia Roig‐Merino, Mehrnaz Ghazvini et al. · 2024 · Genes
  57. Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno‐associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation
    Mengzhen Xie, Lixiang Wang, Yingping Deng, Ke Ma, Hongbo Yin, Xiaolan Zhang, Xingye Xiang, Jin Tang · 2024 · Journal of Ophthalmology
  58. hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity
    Saqlain Suleman, Sharmin Alhaque, Andrew Y. Guo, Huairen Zhang, Annette M. Payne, Marco Zahn, Serena Fawaz, Mohammad S. Khalifa, Susan Jobling, David C. Hay et al. · 2025 · Gene Therapy
  59. Gene Therapy for Sickle Cell Anemia in India - Current Status and Challenges
    Arushi Goel, Varsha Dalal, Rishi Dhawan, Souvik Maiti, Debojyoti Chakraborty · 2025 · Indian Journal of Hematology and Blood Transfusion
  60. Liver-directed lentiviral gene therapy confers durable hepatic and systemic amelioration of methylmalonic acidemia in mice
    Elena Barbon, Chiara Simoni, Amy Argabright, Molly Boettiger, Camilla Negri, Elisabetta Manta, Andrea Raimondi, Elena Vezzoli, Cesare Canepari, Mauro Biffi et al. · 2026 · Journal of Hepatology
  61. From huntingtin gene to Huntington’s disease-altering strategies
    Nicole Déglon · 2017 · Elsevier eBooks
  62. Viral Vector Gene Delivery to the Brain for Treating Neurogenetic Diseases
    Linnet Ramos, Jacqueline E. Hunter, John H N Wolfe · 2017 · Springer eBooks
  63. Optimizing Treatment for Cerebral Adrenoleukodystrophy in the Era of Gene Therapy
    Marc Engelen · 2017 · New England Journal of Medicine
  64. Gene Therapy for Spinal Cord Injury
    Joost Verhaagen, Jared D. Sydney-Smith, Skip Middelhoff, Lieve C. Butter, Fred de Winter, Elizabeth J. Bradbury · 2025 · Springer eBooks
  65. Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cells
    Khanh Ha Nguyen, Soumyajit Das, Sandro Matosevic · 2026 · Med
  66. Rewriting hepatic fate: emerging gene therapy strategies for liver disease
    Ralf Weiskirchen · 2026 · Journal of Translational Genetics and Genomics
  67. Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models
    Andrei Claudiu Cozmescu, Mina Nazari, Loukia Touramanidou, Sonam Gurung, Dany P.B. Perocheau, Neil James Sebire, Yiting Hu, Sian Goldsworthy, Jemima J. Burden, Youssef Khalil et al. · 2026 · Nature Communications
  68. InCliniGene enables high-throughput and comprehensive in vivo clonal tracking toward clinical genomics data integration
    Ivan Merelli, Stefano Beretta, Daniela Cesana, Alessandro Gennari, Fabrizio Benedicenti, Giulio Spinozzi, Daniele Cesini, Eugenio Montini, Daniele D’Agostino, Andrea Calabria · 2023 · Database
  69. Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models
    Archana Shrestha, Devin M. Pillis, Sydney Felker, Mengna Chi, Kimberly Wagner, Oluwabukola T. Gbotosho, Joseph Sieling, Mohammad Shadid, Punam Malik · 2025 · Molecular Therapy — Methods & Clinical Development
  70. Lentiviral Hematopoietic Stem Cell Gene Therapy in Inherited Immune and Lysoso- mal Enzyme Deficiencies
    Gerard Wagemaker · 2016 · Cellular Therapy and Transplantation
  71. Anemi tedavisinde gen düzenleme çalışmaları
    Gulcin Delal Nozhatzadeh Fatih Kocabas- Batuhan Mert Kalkan · 2020 · Gene Editing
  72. Safety of Retroviral Vectors in Clinical Applications: Lessons from Retroviral Biology and Pathogenesis
    James C. Neil · 2017 · Encyclopedia of Life Sciences
  73. [Use of a new peroral anticoryza drug. Experience in the industrial medical practice].
    G Schäfer · 1971 · PubMed
  74. Assessing the Therapeutic Potential of CRISPR/Cas9-Mediated Gene Modulation in Merosin-Deficient Congenital Muscular Dystrophy Type 1A
    Prabhpreet S. Bassi · 2017 · TSpace (University of Toronto)
  75. North Slope pipeline work strong; gas pipeline project deferred
    D. Hale · 1982 · Pipeline Gas J.; (United States)
  76. Therapeutic approaches to imprinting diseases
    Hela Sassi, Léa Guerrini‐Rousseau, Jacques Grill, Étienne Rouleau · 2023 · Elsevier eBooks
  77. Identification of c.146G > A mutation in a Fabry patient and its correction by customized Cas9 base editors in vitro
    Zhi Yang, Hao Li, Mei Luo, Haonan Yi, Xinyu Han, Enze Liu, Shaohua Yao, Zhangxue Hu · 2024 · International Journal of Biological Macromolecules
  78. Response to: Safety and efficacy considerations of HSC-based gene therapy for RAG1-deficient SCID
    Eugenio Montini, Luigi Naldini, Claire Booth, Donald B. Kohn, Alessandro Aiuti · 2025 · Molecular Therapy
  79. Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemia
    Cesare Canepari, Michela Milani, Sara Degl’Innocenti, Marco Monti, Monica Volpin, Francesco Starinieri, Maurizio Cavallo, Anna Fabiano, Mauro Biffi, Marialucia Longo et al. · 2025 · Molecular Therapy
  80. Enhanced transcriptional insulation of lentiviral vectors using “sequence-upgraded polyA long terminal repeats” or “supA-LTRs”
    Jordan Wright, Ben M. Alberts, María Lorena Martínez Quiles, Alessandra Guarino, Daniel Chipchase, Nicholas G. Clarkson, Kyriacos A. Mitrophanous, Daniel C. Farley · 2025 · Molecular Therapy Advances
  81. SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential
    Friederike Mansel, Antonella Lucía Bastone, Philipp John-Neek, Jenni Fleischauer, Violetta Dziadek, Maike Hagedorn, Axel Schambach, Michael Rothe · 2026 · Human Gene Therapy
  82. Génotoxicité des systèmes CRISPR-Cas9.
    Grégoire Cullot · 2019 · theses.fr (ABES)
  83. Measurement and analysis of the protective effects of anti-sickling hemoglobins in sickle cell disease : application to gene therapy strategies
    Nicolas Hebert · 2020 · theses.fr (ABES)
  84. CRISPR-Cas9-based strategies for enhanced targeted integration
    Laurie Lacombe · 2024
  85. Sickle Cell Disease: Historical Overview and Current Therapies
    Oluwaseun O. Babatunde, Madeleine G. Bibby, Anthony Atala, Graça D. Almeida-Porada, Christopher D. Porada · 2026 · Prenatal Diagnosis
  86. Characterization of Lentiviral Vector Products Using Orthogonal Measurements
    Jerilyn R. Izac, Zhiyong He, Linhua Tian, Edward J. Kwee, Sahana Audithan, Lili Wang · 2026 · Cytotherapy
  87. From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott–Aldrich syndrome
    Zahra Karimizadeh, Amirali Kalantari, Maryam Behfar, Dorna Karimizadeh, Leila Jafari, Amir Ali Hamidieh · 2026 · Regenerative Medicine
  88. Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques
    Jian Zhang, Jason Murray, Wenli Mu, Surya Venugopal, Ella Yim, Teresa Einhaus, Stefan Radtke, Christopher W. Peterson, Hans–Peter Kiem, Dong Sung An · 2026 · Viruses
  89. Bioengineering strategies for prenatal therapy
    Elizabeth Reynolds, Diana Lee Farmer, Aijun Wang · 2026 · Nature Reviews Bioengineering